Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-18-034157

President and CEO acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Chan Phillip P. President and CEO 2018-06-11 Option exercise +8,000 $3.75 $30,000 461,281 D
Derivatives
Chan Phillip P. President and CEO 2018-06-11 Option exercise · Common Stock Warrants (right to buy) −8,000 0 D
Loading xslF345X03/tv496464_4.xml…